Skip to main content

Magnetic Resonance Imaging

0
Pipeline Programs
6
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Chia Tai TianQing Pharmaceutical Group
2 programs
Polysaccharide superparamagnetic ferric oxide injectionPHASE_11 trial
polysaccharide superparamagnetic iron oxide injectionPHASE_11 trial
Active Trials
NCT05687864Unknown30Est. Dec 2023
NCT06010537Completed4Est. Apr 2021
Boston Scientific
Boston ScientificCA - Valencia
1 program
ImageReady MR Conditional Defibrillation SystemN/A1 trial
Active Trials
NCT02652481Completed500Est. May 2018
Guerbet
GuerbetFrance - Villepinte
1 program
DOTAREMPHASE_41 trial
Active Trials
NCT02411201Completed51Est. Oct 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GuerbetDOTAREM
Chia Tai TianQing Pharmaceutical GroupPolysaccharide superparamagnetic ferric oxide injection
Chia Tai TianQing Pharmaceutical Grouppolysaccharide superparamagnetic iron oxide injection
Boston ScientificImageReady MR Conditional Defibrillation System

Clinical Trials (4)

Total enrollment: 585 patients across 4 trials

NCT02411201GuerbetDOTAREM

DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years

Start: Mar 2015Est. completion: Oct 201551 patients
Phase 4Completed
NCT05687864Chia Tai TianQing Pharmaceutical GroupPolysaccharide superparamagnetic ferric oxide injection

Study of Polyglycan Superparamagnetic Ferric Oxide Injection on Cardiovascular Magnetic Resonance Imaging

Start: Jun 2023Est. completion: Dec 202330 patients
Phase 1Unknown
NCT06010537Chia Tai TianQing Pharmaceutical Grouppolysaccharide superparamagnetic iron oxide injection

Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle

Start: Apr 2021Est. completion: Apr 20214 patients
Phase 1Completed
NCT02652481Boston ScientificImageReady MR Conditional Defibrillation System

ENABLE MRI (Magnetic Resonance Imaging)

Start: Jan 2016Est. completion: May 2018500 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.